27. Deutscher Krebskongress
Deutsche Krebsgesellschaft e. V.
22. - 26.03.2006, Berlin
Leukemia / Lymphoma / Stem Cell Transplantation
Meeting Abstract
(OP101)
[Volltext]
Functional diagnosis of residual lymphomas after radiochemotherapy with positron emission tomography
Wuchter P, Kasper B, Lehnert T, Ho AD, Haberkorn U, Egerer G[Volltext]
Meeting Abstract
(OP102)
[Volltext]
First line therapy with Fludarabine (F) versus Chlorambucil (CLB) in elderly patients (PTS) with advanced CLL: results of a multicentre phase III study (CLL5 protocol) of the German CLL Study Group (GCLLSG)
Eichhorst B, Busch R, Stauch M, Bergmann M, Ritgen M, Kranzhöfer N, Rohrberg R, Söling U, Burkhard O, Emmerich B, Brittinger G, Hallek M[Volltext]
Meeting Abstract
(OP103)
[Volltext]
The AML1-ETO Fusion Gene and the FLT3 Length Mutation Collaborate in Inducing Acute Leukemia in a Murine Bone Marrow Transplantation Model
Scheßl C, Rawat VPS, Cusan M, Deshpande A, Kohl TM, Rosten PM, Spiekermann K, Humphries RK, Schnittger S, Kern W, Hiddemann W, Quintanilla-Martinez L[Volltext]
Meeting Abstract
(OP104)
[Volltext]
Diagnosis of Burkitt’s lymphoma in due time: a practical approach
Barth TFE, Novak U, Henz S, Schmid U, Möller P, Cogliatti SB[Volltext]
Meeting Abstract
(OP105)
[Volltext]
Leukemia targeting ligands isolated from phage display peptide libraries
Adebahr S, Jahnke A, Jäger S, Berg T, Lübbert M, Trepel M[Volltext]
Meeting Abstract
(OP106)
[Volltext]
Bisphosphanate activity beyond bone preservation: Direct anti-tumor effects of zoledronate
Günther A, Gordon S, Bakker F, Burger R, Tiemann M, Green JR, Rogers M, Gramatzki M[Volltext]
Meeting Abstract
(PO107)
[Volltext]
Treatment Situation For Newly Diagnosed Multiple Myeloma (MM) Patients In Germany (GER)- First Results From A Representative Multicentre Treatment Survey
Freund M, Knauf W, Goldschmidt H, Einsele H, Nowrousian MR, Berdel WE, Poenisch W, Straka C, Kellermann L, Bammer S, Angermund R[Volltext]
Meeting Abstract
(PO108)
[Volltext]
The oncogenic potential of the homeobox gene Cdx2 is depending on the N-terminal transactivation domain in vivo and can be antagonized by inhibition of the MAPK pathway in a mouse model of t(12;13)(p13;q12) positive AML
Rawat VPs, Arseni N, Naidu MV, Suh RE, Lynch JP, Hiddemann W, Feuring-Buske M, Buske C[Volltext]
Meeting Abstract
(PO109)
[Volltext]
Similarities and differences of human healthy and malignant hematopoietic stem cells
Lannert H, Able T, Franz T, Bathke A, Hofmann R, Lenze A, Horsch K, Eckstein V, Saffrich R, Ho AD[Volltext]
Meeting Abstract
(PO110)
[Volltext]
Late cardiac toxicity in Hodgkin's disease survivors after mediastinal radiotherapy: investigation using cardiac MRI
Vordermark D, Seufert I, Schwab F, Kölbl O, Kung M, Machann W, Flentje M, Angermann C, Beer M[Volltext]
Meeting Abstract
(PO111)
[Volltext]
Fludarabine (Fludara®) ist highly effective and safe treatment of advanced CLL also in elderly and comorbid patients: Interim analysis of a quality assurance documentation in the oncological practice
Tschechne B, Luft S, Meyer D, Blumenstengel K, Däßler KU, Detken S, Marquard F, Hinrichs HF, Otremba B, Tessen HW, Ammon A, von Wussow P[Volltext]
Meeting Abstract
(PO112)
[Volltext]
Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyclophosphamide and rituximab for relapsed B cell lymphoma
Meisinger I, Weisel K, Hartmann JT[Volltext]
Meeting Abstract
(PO113)
[Volltext]
Bendamustine in Combination with Thalidomide and Prednisolone (BPT) in Patients with Refractory or Relapsed Multiple Myeloma: Results of a Phase I Clinical Trial
Pönisch W, Rozanski M, Goldschmidt H, Hoffmann FA, Boldt T, Ruffert U, Rohrberg R, Schwarzer A, Schwalbe E, Kreibich U, Haak U, Niederwieser D[Volltext]
Meeting Abstract
(PO114)
[Volltext]
Role Of Bortezomib In The Treatment Of Multiple Myeloma - First Results From a Representative Multicentre Treatment Survey in Germany (GER)
Angermund R, Knauf W, Freund M, Nowrousian MR, Einsele H, Goldschmidt H, Berdel WE, Poenisch W, Straka C, Kellermann L, Bammer S[Volltext]
Meeting Abstract
(PO115)
[Volltext]
Individualised Therapy in Geriatric Patients with Non-Hodgkin Lymphoma - Report of a Single Center
Schroeder M, Greiff U, Dastgir-Saadat T, Noack C, Schäfer U[Volltext]
Meeting Abstract
(PO116)
[Volltext]
Inpatient rehabilitation for patients wih multiple myeloma / plasmacytoma: Rehabilitation needs and effects of an integrative program Stationäre Rehabilitation für Patienten mit Multiplem Myelom / Plasmozytom: Rehabilitationsbedarf und Effekte eine integrativen Programms
Mumm A, Weis J, Poppelreuter M, Bartsch HH[Volltext]
Meeting Abstract
(PO117)
[Volltext]
Subcutaneous Taenia crassiceps infection in a patient with Non Hodgkin’s lymphoma with prolonged immunosuppression after fludarabine and cyclophosphamide therapy
Heldwein K, Kubin T, Tappe D, LaRegina D, Bretzel G, Löscher T, Büttner D, Biedermann HG[Volltext]
Meeting Abstract
(PO118)
[Volltext]
Radioimmunotherapy with Y-90 labelled anti-CD45 monoclonal antibodies induces DNA-damage and activates apoptosis pathways in vivo
Friesen C, Debatin KM, Bunjes D, Reske SN[Volltext]
